RYR2 may be more expressed than RYR1 and RYR3 in tissues such as lung and gastrointestinal organs and tract, where the incidence of cancers is high, and this may lead to the identification of more mutations predominantly in RYR2 than RYR1 or RYR3. This evidence concerns the gene RYR2 and cancer.